Janux Therapeutics, Inc. Profile Avatar - Palmy Investing

Janux Therapeutics, Inc.

Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are i…

Biotechnology
US, La Jolla [HQ]

Risk Factors

By Management
Not Available

    No Risk Factor available yet. You can request "Risk Factors" through an email.

End of JANX's Analysis
CIK: 1817713 CUSIP: 47103J105 ISIN: US47103J1051 LEI: - UEI: -
Secondary Listings
JANX has no secondary listings inside our databases.